Jim Kramer here to share a short preview of my take on the market from today's

members-only CNBC Investing Club Morning Meeting.

Join the club for full access to the morning meeting every day at 1020 a.m.

Visit CNBC.com slash morning take to sign up today.

That's one word, morning take. Last week, Jim, we also saw this

magnificent rotation into health care stocks that, you know, they were tough to own for the better

part of the quarter. But they finally come to live all at or near alltime highs, Cardinal Health, Jay and Jay, Lilly.

Remember I said that this is ridiculous.

We bought some dinner.

Ridiculous.

We did sell some higher, but we got a nice basis now.

Ridiculous because the quarter was great.

He got caught up in a rotation.

Jason Holler did a magnificent job, the CEO.

It was a congratulations quarter, and yet the stock got hit.

But it was totally the rotation, as is Merck.

Cardinal Health actually may not be done going higher.

I remember I said that when it gets here, suddenly people say, wow,

Cardinal Health is back.

Let's go buy some. Now, I am in the opinion that we're being say, wow, cardinal health is back, let's go buy some.

Now, I am in the opinion that we're being pigs, having bought a lot, so that's why we've let some go.

But what you have when you look at this, or when you look at Eli Lilly, which is a rather

...